Cargando…
Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361752/ https://www.ncbi.nlm.nih.gov/pubmed/37485262 http://dx.doi.org/10.3389/fcvm.2023.1152280 |
_version_ | 1785076278274031616 |
---|---|
author | Mussayev, Abdurashid Alimbayev, Serik Tanaliev, Nursultan Kuanyshbek, Aidyn Marat, Aripov Lesbekov, Timur Raissov, Yerkezhan Sadykova, Aigerim Kamila, Askarovna Kenzhebayeva Mukarov, Murat Pya, Yuriy |
author_facet | Mussayev, Abdurashid Alimbayev, Serik Tanaliev, Nursultan Kuanyshbek, Aidyn Marat, Aripov Lesbekov, Timur Raissov, Yerkezhan Sadykova, Aigerim Kamila, Askarovna Kenzhebayeva Mukarov, Murat Pya, Yuriy |
author_sort | Mussayev, Abdurashid |
collection | PubMed |
description | Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative mortality. Hence, transcatheter tricuspid repair and replacement procedures are preferred. More recently, transcatheter valve-in-valve (ViV) treatments have gained importance because of their less invasiveness, especially for patients with prior surgeries. Encouraging evidence of the safety and effectiveness of a novel balloon-expandable (BE) transcatheter heart valve (THV)—the Myval THV—has been reported for ViV procedures. Here, we present a case-series of 5 patients, in whom tricuspid ViV procedure was performed using BE Myval THV, implanted supra-annularly by anchoring onto the deteriorated BHV. This case-series details the procedural steps to prevent in-hospital adverse events and early (30-day) mortality and the challenges during tricuspid ViV interventions. |
format | Online Article Text |
id | pubmed-10361752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103617522023-07-22 Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up Mussayev, Abdurashid Alimbayev, Serik Tanaliev, Nursultan Kuanyshbek, Aidyn Marat, Aripov Lesbekov, Timur Raissov, Yerkezhan Sadykova, Aigerim Kamila, Askarovna Kenzhebayeva Mukarov, Murat Pya, Yuriy Front Cardiovasc Med Cardiovascular Medicine Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative mortality. Hence, transcatheter tricuspid repair and replacement procedures are preferred. More recently, transcatheter valve-in-valve (ViV) treatments have gained importance because of their less invasiveness, especially for patients with prior surgeries. Encouraging evidence of the safety and effectiveness of a novel balloon-expandable (BE) transcatheter heart valve (THV)—the Myval THV—has been reported for ViV procedures. Here, we present a case-series of 5 patients, in whom tricuspid ViV procedure was performed using BE Myval THV, implanted supra-annularly by anchoring onto the deteriorated BHV. This case-series details the procedural steps to prevent in-hospital adverse events and early (30-day) mortality and the challenges during tricuspid ViV interventions. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10361752/ /pubmed/37485262 http://dx.doi.org/10.3389/fcvm.2023.1152280 Text en © 2023 Mussayev, Alimbayev, Tanaliev, Kuanyshbek, Aripov, Lesbekov, Raissov, Sadykova, Kamila, Mukarov and Pya. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Mussayev, Abdurashid Alimbayev, Serik Tanaliev, Nursultan Kuanyshbek, Aidyn Marat, Aripov Lesbekov, Timur Raissov, Yerkezhan Sadykova, Aigerim Kamila, Askarovna Kenzhebayeva Mukarov, Murat Pya, Yuriy Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title_full | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title_fullStr | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title_full_unstemmed | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title_short | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
title_sort | case report: transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361752/ https://www.ncbi.nlm.nih.gov/pubmed/37485262 http://dx.doi.org/10.3389/fcvm.2023.1152280 |
work_keys_str_mv | AT mussayevabdurashid casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT alimbayevserik casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT tanalievnursultan casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT kuanyshbekaidyn casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT marataripov casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT lesbekovtimur casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT raissovyerkezhan casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT sadykovaaigerim casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT kamilaaskarovnakenzhebayeva casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT mukarovmurat casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup AT pyayuriy casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup |